Search Results - "Burris HA III"

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.

Authors: Karacin, Cengiz Oksuzoglu, Berna Demirci, Ayşe et al.

Source: BMC Cancer. 2/13/2023, Vol. 23 Issue 1, p1-10. 10p.

A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.

Authors: Kodama, Tomoko Imajima, Takashi Shimokawa, Mototsugu et al.

Source: Scientific Reports. 5/30/2024, Vol. 14 Issue 1, p1-10. 10p.

The role of everolimus in malignant bone tumor therapy: Molecular mechanisms, preclinical evidence, and advances in clinical applications.

Authors: Zhang, Youshu Dong, Yao Zhang, Yao et al.

Source: Oncology Reviews. 2025, p1-11. 11p.

Recent progress and structural insights of potential Hsp90 inhibitors as anticancer agents.

Authors: Singh A Maity S Devi P et al.

Source: Molecular diversity [Mol Divers] 2025 Dec; Vol. 29 (6), pp. 5335-5366. Date of Electronic Publication: 2025 Mar 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: ESCOM Science Publishers Country of Publication: Netherlands NLM ID: 9516534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-501X (Electronic) Linking ISSN: 13811991 NLM ISO Abbreviation: Mol Divers Subsets: MEDLINE

Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art.

Authors: Paraïso, P. van Deurzen, C. H. M. Seimbille, Y.

Source: EJNMMI Radiopharmacy & Chemistry. 4/26/2026, Vol. 11 Issue 1, p1-33. 33p.

Advancing antibody drug conjugates in gastrointestinal cancers.

Authors: Cassier PA Izarn F Dumontet C et al.

Source: British journal of cancer [Br J Cancer] 2026 Jul 23. Date of Electronic Publication: 2026 Jul 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Recent advances in the regulation of CD47 by non-coding RNAs and its therapeutic potential in cancer.

Authors: Hua J Zhu W Sun X et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May 07. Date of Electronic Publication: 2026 May 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis.

Authors: Yeh, Randy Pareja, Fresia Shobeiri, Parnian et al.

Source: Journal of Nuclear Medicine. Jun2025, Vol. 66 Issue 6, p873-879. 7p.

Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies.

Authors: Chen, Shuchen Zhu, Honglin Jin, Meizi et al.

Source: Cancer Medicine. Nov2022, Vol. 11 Issue 22, p4122-4133. 12p.

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

Authors: Yılmaz, Feride Yaşar, Serkan Tatar, Ömer Denizhan et al.

Source: BMC Cancer. 10/1/2024, Vol. 24 Issue 1, p1-11. 11p.

Circulating tumor DNA dynamics predict pathological response and guide therapy personalization in the neoadjuvant setting.

Authors: Ahmed HM Al-Hussainy AF Mustafa WW et al.

Source: Discover oncology [Discov Oncol] 2026 Jan 30; Vol. 17 (1). Date of Electronic Publication: 2026 Jan 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

Deployment of a Machine Learning Algorithm in a Real-World Cohort for Quality Control Monitoring of Human Epidermal Growth Factor-2--Stained Clinical Specimens in Breast Cancer.

Authors: Glass, Benjamin Vandenberghe, Michel E. Chavali, Surya Teja et al.

Source: Archives of Pathology & Laboratory Medicine. Aug2025, Vol. 149 Issue 8, p751-760. 10p.

Elucidating the impact of cottonseed hydrolysates on CHO cell culture performance through transcriptomic analysis.

Authors: Kumar, Swetha Dhara, Venkata Gayatri Orzolek, Linda D. et al.

Source: Applied Microbiology & Biotechnology; 2021, Vol. 105 Issue 1, p271-285, 15p

Atomic degradation: chemical design strategies and immunotherapeutic mechanisms of radio-PROTACs.

Authors: Ören Varol T Varol M

Source: Annals of nuclear medicine [Ann Nucl Med] 2026 Jul 01. Date of Electronic Publication: 2026 Jul 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 8913398 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1864-6433 (Electronic) Linking ISSN: 09147187 NLM ISO Abbreviation: Ann Nucl Med Subsets: MEDLINE

A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.

Authors: Zhou, Mingzhen Jin, Yuncheng Zhu, Sihui et al.

Source: Clinical & Translational Immunology. 2024, Vol. 13 Issue 1, p1-11. 11p.

Efficacy of everolimus‐based therapy in advanced triple‐positive breast cancer: Experience from three cancer centers in China.

Authors: Tan, Yujing Jiang, Hanfang Ma, Fei et al.

Source: Thoracic Cancer. Dec2023, Vol. 14 Issue 34, p3397-3405. 9p.

Anastrozole‐related dermatitis with mainly unilateral distribution.

Authors: Mizuta, Takahiro Kato, Miyuki

Source: Australasian Journal of Dermatology. May2022, Vol. 63 Issue 2, pe173-e175. 3p. 2 Color Photographs.

Drug‐induced radiation recall reactions and non‐anticancer drugs: A descriptive analysis from VigiBase®.

Authors: Aubin‐Beale, Eyrian Giorgi, Lorene Beurrier, Mathilde et al.

Source: Fundamental & Clinical Pharmacology. Jun2023, Vol. 37 Issue 3, p673-679. 7p.

Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).

Authors: Kehmann, Linde Berres, Marie-Luise Gonzalez-Carmona, Maria et al.

Source: BMC Cancer. 5/22/2023, Vol. 23 Issue 1, p1-12. 12p.

Dosing Recommendation Based on the Effects of Different Meal Types on Pexidartinib Pharmacokinetics in Healthy Subjects: Implementation of Model‐informed Drug Development Strategy.

Authors: Zahir, Hamim Yin, Ophelia Hsu, Ching et al.

Source: Clinical Pharmacology in Drug Development. May2023, Vol. 12 Issue 5, p475-483. 9p.